Polyrizon Ltd.
Support and Resistance Levels
Past performance
News About PLRZ
All events for PLRZ
All deals for PLRZ
Financial Ratios
Financial Statements
PLRZ vs Sector & Peers
About Polyrizon Ltd.
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel. Website polyrizon-biotech.com
Headquarters Ra'anana, TA, IL